Adjuvant Nivolumab Promising in Resected Merkel Cell Carcinoma
Absolute risk reduction of 9-10% in 1- and 2-year DFS compared with observation
Source: medpagetoday.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Philippe Saiag. Real-time updates on events, politics, business and more.